Marc Cartellieri - cellex patient treatment GmbH

基本信息

浏览量：50

职业迁徙

个人简介

Cell therapy with focus on CAR-T

研究兴趣

论文共 96 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Impact of different -chain cytokines on clinical car t cell manufacturing

N. Jacob, J. Riewaldt, J. Reinhardt, J. Dietrich, L. Zimmermann, D. Silva Apango, M. Langer, J. Spehr, S. Loff,R. Lescarbeau,A. Ehninger,M. Cartellieri

HUMAN GENE THERAPYno. 21-22 (2023): A8-A8

引用0浏览0引用

Preclinical characterization of switchable allogeneic chimeric antigen receptor T cells to support first in human clinical study in CD123-positive hematologic and lymphatic malignancies

Armin Ehninger,Johannes Spehr,Simon Loff, Anika Langer,Julia Riewaldt, Julia Reinhardt,Jan-Erik Meyer,Josephine Dietrich, Gabriel Jurado,Reynald Lescarbeau,Marc Cartellieri

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

Abstract 4095: Preclinical Characterization of Switchable Allogeneic Chimeric Antigen Receptor T Cells to Support First in Human Clinical Study in CD123-positive Hematologic and Lymphatic Malignancies

Armin Ehninger,Johannes Spehr,Simon Loff, Anika Langer,Julia Riewaldt, Julia Reinhardt,Jan-Erik Meyer,Josephine Dietrich, Gabriel Jurado,Reynald Lescarbeau,Marc Cartellieri

Cancer Researchno. 7_Supplement (2023): 4095-4095

引用0浏览0引用

Functional Characterization and Optimization of Switchable Allogeneic Chimeric Antigen Receptor T Cells for Targeting CD19 and CD20 in B Cell Malignancies

Johannes Spehr,Jan-Erik Meyer,Simon Loff, Anika Langer, Moritz Langer, Ben Boyerinas, Isabelle Le Mercier,Reynald Lescarbeau,Marc Cartellieri,Armin Ehninger

Bloodno. Supplement 1 (2023): 2059-2059

引用0浏览0引用

Impact of co-stimulation on in vitro persistence of a modular chimeric antigen receptor platform

L. Zimmermann, S. Loff, A. Langer, J-E Meyer, D. Silva Apango, N. Jacob, G. Ehninger,M. Cartellieri, J. Spehr,A. Ehninger

HUMAN GENE THERAPYno. 21-22 (2023): A25-A25

引用0浏览0引用

Updated Results from a Phase I Dose Escalation Study of the Rapidly-Switchable Universal CAR-T Therapy UniCAR-T-CD123 in Relapsed/Refractory AML

Martin Wermke,Stephan Metzelder,Sabrina Kraus,Elisa Sala,Vladan Vucinic,Walter Fiedler,Katrin Wetzko,Jonas Schaefer,Maria-Elisabeth Goebeler,Jan Koedam,Kristin Franke, Matti Vaenskae,Armin Ehninger,Marc Cartellieri,Gerhard Ehninger,Tapan Maniar

BLOOD (2023)

引用0浏览0引用

Chimeric Antigen Receptor T-cell Therapy in Acute Myeloid Leukemia

Jan Koedam,Martin Wermke,Armin Ehninger,Marc Cartellieri,Gerhard Ehninger

Current opinion in hematology/Current opinion in hematology, with evaluated MEDLINE（2022）

引用12浏览0引用

Phase 1 Dose Escalation Study of the Rapidly Switchable Universal CAR-T Therapy Unicar-T-CD123 in Relapsed/Refractory AML

Gerhard Ehninger,Sabrina Kraus,Elisa Sala,Stephan K. Metzelder,Vladan Vucinic,Walter Fiedler,Maria-Elisabeth Goebeler,Jan Moritz Middeke,Malte von Bonin,Carla Kreissig,Jan Koedam,Marc Cartellieri,Armin Ehninger,Martin Wermke,Jonas A. Schaefer

Blood（2022）

引用3浏览0引用

Abstract 1506: Expansion Kinetics and Cytokine Profiles of UniCAR-T-CD123, a Rapidly Switchable Two-Component CAR-T Therapy, in Patients with Relapsed/refractory AML

Armin Ehninger,Julia Riewaldt,Cordula Gründer,Kristin Franke,Maria Schreiber,Martin Wermke,Sabrina Kraus,Carla Kreissig,Jan Koedam,Michael Pehl,Gerhard Ehninger,Marc Cartellieri

Cancer research（2021）

引用1浏览0引用

Proof of Concept for a Rapidly Switchable Universal CAR-T Platform with UniCAR-T-CD123 in Relapsed/refractory AML

Martin Wermke,Sabrina Kraus,Armin Ehninger,Ralf C. Bargou,Maria-Elisabeth Goebeler,Jan Moritz Middeke,Carla Kreissig,Malte von Bonin,Jan Koedam,Michael Pehl,Martin Bornhaeuser,Hermann Einsele,Gerhard Ehninger,Marc Cartellieri

Bloodno. 22 (2021): 3145-3148

引用62浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn